Endurance Wealth Management, Inc. Amarin Corp Plcuk Transaction History

Endurance Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$3.24 - $5.18 $6,480 - $10,360	-2,000 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$4.26 - $6.5 $12,780 - $19,500	-3,000 Reduced 60.0%	2,000 $8,000
Q4 2020 Jan 15, 2021	BUY	$4.04 - $5.31 $12,120 - $15,929	3,000 Added 150.0%	5,000 $24,000
Q1 2020 May 11, 2020	SELL	$4.0 - $21.53 $2,000 - $10,765	-500 Reduced 20.0%	2,000 $8,000
Q3 2019 Oct 18, 2019	BUY	$13.89 - $23.16 $13,890 - $23,160	1,000 Added 66.67%	2,500 $37,000

Q2 2019 Jul 30, 2019	BUY	$16.27 - $20.51 $8,135 - $10,255	500 Added 50.0%	1,500 $29,000
Q4 2018 Jan 14, 2019	BUY	$12.41 - $22.98 $12,410 - $22,980	1,000 New	1,000 $14,000

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $278M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.